期刊文献+

血管内支架在冠状动脉复杂病变成形术中的临床应用 被引量:3

Clinical application of coronary stent for complex coronary lesions
下载PDF
导出
摘要 目的 探讨血管内支架在冠状动脉复杂病变成形术中的应用效果及价值。方法 对冠心病患者复杂冠状动脉病变在经皮穿刺冠状动脉成形术 (PTCA)并发急性血管内闭塞、内膜严重撕裂、术后显著残留狭窄及短期内再狭窄等情况下进行了血管内支架植入术 (CASI)。结果  31例患者CASI均获成功 ,术后急性血管闭塞和内膜撕裂征象消失 ,残留狭窄及再狭窄解除 ,未出现出血和穿刺部位血管并发症及CASI后亚急性血栓形成。随访 16例 ,1例术后 13天发生猝死 ;2例因胸痛复发经造影证实支架血管再狭窄 ,再次球囊扩张后再狭窄改善 ;余 13例冠状动脉造影示支架血管正常。结论 冠心病复杂冠状动脉病变行CASI是解除PTCA急性并发症的安全、有效和可行的方法 ,并有助于PTCA后再狭窄的防治。 Objective To evaluate the clinical results of intracoronary implantation of stents in coronary heart disease patients with complex coronary lesions.Methods 42 steel stents were implanted into coronary artery of 31 patients;Results All stents were implanted successfully with uneventful sequence and few complication.The acute occlusion and dissection disappeared,while the residual stenoses and restenoses were reduced signifcantly after stent implantation.No other stent-subacute thrombosis or severe bleeding were observed in hospital stay.Restenosis was found in 2 cases and one sudden death occurred 13 days after stenting within 16 cases during follow-ups.Conclusion It is suggested that intracoronary stenting is a safe and efficient interventional procedure for prevention and treatment of acute complications following PCTA,and can reduce the formation of coronary restenosis as well.
出处 《中国全科医学》 CAS CSCD 2000年第5期362-363,共2页 Chinese General Practice
关键词 冠心病 冠状动脉支架术 PTCA CASI Coronary artery disease Intracoronary stent Complex coronary lesion
  • 相关文献

参考文献4

  • 1Jischman DL,Leou MB,Baim DS,et al.A randomized comparision of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease[].The New England Journal of Medicine.1994
  • 2Eric E,Kappenberger L,Goy JJ.Stents for intracoronary placement:Current status and future directions[].Journal of the American College of Cardiology.1996
  • 3Schomig A,Neumann FJ,Kastrati A,et al.A randomised comparison of antiplatelet and anticoagutant therapy after the placement of coronary artery stents[].The New England Journal of Medicine.1996
  • 4George BS,Voorhees WD,Roubin GS,et al.Multicenter inverstigation of coronary stenting to treat acute or threatened closure after PTCA clinical and angiographic outcomes[].Journal of the American College of Cardiology.1993

同被引文献22

  • 1李芳,王琳,卜军.替罗非班治疗急性冠脉综合征的临床研究[J].内科急危重症杂志,2004,10(2):72-74. 被引量:17
  • 2郭来敬,唐强,胡大一.国产盐酸替罗非班在急诊经皮冠状动脉介入治疗中临床应用的研究[J].临床荟萃,2006,21(23):1697-1700. 被引量:15
  • 3Iakovou I,Schmidt T, Bonizzoni E, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents[J]. JAMA,2005,293(17) :2126-2130.
  • 4Kastrati A, Elezi S, Dirsehinger J, et al. Influence of lesion length on restenosis after coronary stent placement[J]. Am J Cardiol, 1999,83(12): 1617-1622.
  • 5Cho L, Topoi EJ,Balog C. et al. Clinical benefit of glyeoprotein Ⅱb/Ⅲa blockade with Abciximab is independent of gender: pooled analysis from EPIC, EPILOG and EPISTENT trials.Evaluation of 7E3 for the Prevention of Ischemic Complications. Evaluation in Percutaneous Transluminal Coronary Angioplasty to Improve Long-Term Outcome with Abciximab GP Ⅱb/Ⅲa blockade. Evaluation of Platelet Ⅱb/Ⅲa Inhibitor for Stent[J]. J Am Coll Cardiol, 2000, 36 (2) : 381-386.
  • 6Kuchulakanti P,Rha SW,Satler LF,et al. Impact of major side branch on periprocedural enzyme elevation and long-term outcome in patients undergoing percutaneous coronary intervention and brachytherapy for in-stent restenosis [J]. Am J Cardiol,2004,93(11):1394-1397.
  • 7Valgimigli M, Percoco G, Malagutti P, et al. Tirofiban and sirolimus-eluting stent vs abciximab and bare-metal stent for acute myocardial infarction: a randomized trial[J]. JAMA, 2005,293(17) :2109-2117.
  • 8Warnhohz A, Ostad MA, Heitzer T, et al. Effect of tirofiban on percutaneous coronary intervention-induced endothelial dysfunction in patients with stable coronary artery disease[J]. Am J Cardiol,2005,95(1):20-23.
  • 9de Luea G, Smit JJ, Ernst N, et al. Impact of adjunctive tirofiban administration on myocardial perfusion and mortality in patients undergoing primary angioplasty for ST-segment elevation myocardial infarction[J]. Thromb Haemest, 2005,93 (5) :820-823.
  • 10Anonymous. Use of a monoclonal antibody directed against the platelet glycoprotein Ⅱb/Ⅲa receptor in high-risk coronary angioplasty. The EPIC Investigation [J]. N Engl J Med, 1994, 330(14) :956-961.

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部